GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | 8/12/2026 7:24:34 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $19,896,000 +27.1% | Assets $110,336,000 | EPS $0.05 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/12/2026 7:01:19 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $19,896,000 +27.1% | Assets $110,336,000 | EPS $0.05 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/13/2026 7:14:11 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $33,750,000 +233.7% | Assets $102,336,000 | EPS $0.22 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/13/2026 6:58:36 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $33,750,000 +233.7% | Assets $102,336,000 | EPS $0.22 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/30/2026 6:41:13 PM | View | Proxy | SEC | Y 2025 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2026 7:24:35 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $52,744,000 -1.2% | Assets $82,346,000 | EPS $0.08 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2026 7:21:18 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $9,122,000 -49.9% | Assets $82,346,000 | EPS $0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/13/2025 7:06:31 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $17,851,000 -0.6% | Assets $82,264,000 | EPS $0.03 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/13/2025 6:56:27 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $17,851,000 -0.6% | Assets $82,264,000 | EPS $0.03 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/14/2025 7:13:06 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $15,658,000 +16.2% | Assets $78,486,000 | ||
| Protalix BioTherapeutics, Inc. (PLX) | 8/14/2025 6:59:16 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $15,658,000 +16.2% | Assets $78,486,000 | Export Earnings Model | ||
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2025 7:12:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $10,113,000 +169.8% | Assets $73,892,000 | EPS -$0.05 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2025 6:57:49 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $10,113,000 +169.8% | Assets $73,892,000 | EPS -$0.05 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/30/2025 4:58:07 PM | View | Proxy | SEC | Y 2024 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/17/2025 7:26:35 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $53,399,000 -18.5% | Assets $73,417,000 | EPS $0.04 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/17/2025 6:56:59 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $18,218,000 +73.7% | Assets $73,417,000 | EPS $0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/14/2024 7:11:28 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $17,959,000 +73.6% | Assets $61,563,000 | EPS $0.03 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/14/2024 6:58:17 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $17,959,000 +73.6% | Assets $61,563,000 | EPS $0.03 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/14/2024 7:17:43 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $13,474,000 -61.6% | Assets $91,540,000 | EPS -$0.03 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/14/2024 6:57:33 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $13,474,000 -61.6% | Assets $91,540,000 | EPS -$0.03 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/10/2024 7:34:44 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $3,748,000 -60.9% | Assets $89,825,000 | EPS -$0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/10/2024 7:00:49 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $3,748,000 -60.9% | Assets $89,825,000 | EPS -$0.06 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/29/2024 4:59:33 PM | View | Proxy | SEC | Y 2023 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/14/2024 7:18:31 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $65,494,000 +37.5% | Assets $84,434,000 | EPS $0.09 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/14/2024 6:59:09 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $10,486,000 +21.7% | Assets $84,434,000 | EPS -$0.07 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/6/2023 8:06:56 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $10,345,000 -27.1% | Assets $87,569,000 | EPS -$0.04 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/6/2023 7:23:56 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $10,345,000 -27.1% | Assets $87,569,000 | EPS -$0.04 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/7/2023 7:14:32 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $35,075,000 +300.7% | Assets $88,417,000 | EPS $0.21 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/7/2023 7:00:42 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $35,075,000 +300.7% | Assets $88,417,000 | EPS $0.21 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/18/2023 5:01:44 PM | View | Proxy | SEC | Y 2022 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 5/4/2023 4:54:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $9,588,000 -40.4% | Assets $66,559,000 | EPS -$0.05 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/4/2023 7:41:06 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $9,588,000 -40.4% | Assets $66,559,000 | EPS -$0.05 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/1/2023 6:59:24 AM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $47,638,000 +24.2% | Assets $55,787,000 | EPS -$0.31 | |
| Protalix BioTherapeutics, Inc. (PLX) | 2/27/2023 6:56:50 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $47,638,000 +24.2% | Assets $55,787,000 | EPS -$0.31 | |
| Protalix BioTherapeutics, Inc. (PLX) | 2/27/2023 6:37:24 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $8,617,000 +0.8% | Assets $55,787,000 | EPS -$0.07 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/14/2022 7:17:37 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $14,183,000 +17.7% | Assets $56,709,000 | EPS -$0.07 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/14/2022 7:04:27 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $14,183,000 +17.7% | Assets $56,709,000 | EPS -$0.07 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/15/2022 7:29:22 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $8,753,000 +36.2% | Assets $60,640,000 | EPS -$0.11 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/15/2022 7:20:10 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $8,753,000 +36.2% | Assets $60,640,000 | EPS -$0.11 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/16/2022 7:31:58 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $16,085,000 +42.1% | Assets $68,391,000 | EPS -$0.05 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/16/2022 7:07:23 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $16,085,000 +42.1% | Assets $68,391,000 | EPS -$0.05 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/29/2022 4:57:41 PM | View | Proxy | SEC | Y 2021 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/31/2022 7:27:28 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $38,350,000 -39.0% | Assets $73,665,000 | EPS -$0.62 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/31/2022 7:03:49 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $8,549,000 -56.1% | Assets $73,665,000 | EPS -$0.14 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/15/2021 7:35:01 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $12,054,000 +11.7% | Assets $83,482,000 | EPS -$0.09 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/15/2021 7:14:15 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $12,054,000 +11.7% | Assets $83,482,000 | EPS -$0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 9/30/2021 4:32:05 PM | View | Proxy | SEC | Y 2020 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/16/2021 7:31:29 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $6,427,000 -41.4% | Assets $108,204,000 | EPS -$0.25 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/16/2021 7:12:03 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $6,427,000 -41.4% | Assets $108,204,000 | EPS -$0.25 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 6/4/2021 4:32:29 PM | View | Proxy | SEC | Y 2020 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 5/14/2021 7:15:44 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $11,320,000 -47.7% | Assets $102,792,000 | EPS -$0.14 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/14/2021 6:58:05 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $11,320,000 -47.7% | Assets $102,792,000 | EPS -$0.14 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/30/2021 6:53:10 AM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $62,898,000 +15.0% | Assets $67,934,000 | EPS -$0.22 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/30/2021 7:44:25 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $62,898,000 +15.0% | Assets $67,934,000 | EPS -$0.22 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/30/2021 7:04:23 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $19,495,000 +9.8% | Assets $67,934,000 | EPS $0.03 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/29/2020 7:32:52 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $10,790,000 -24.3% | Assets $72,310,000 | EPS -$0.14 | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/29/2020 7:12:58 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $10,790,000 -24.3% | Assets $72,310,000 | EPS -$0.14 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/10/2020 7:14:41 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $10,967,000 -10.5% | Assets $71,710,000 | EPS -$0.13 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/10/2020 6:57:31 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $10,967,000 -10.5% | Assets $71,710,000 | EPS -$0.13 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 6/1/2020 7:15:13 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $21,646,000 +107.4% | Assets $82,876,000 | EPS $0.10 | |
| Protalix BioTherapeutics, Inc. (PLX) | 6/1/2020 7:01:58 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $21,646,000 +107.4% | Assets $82,876,000 | EPS $0.10 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/15/2020 4:31:48 PM | View | Proxy | SEC | Y 2019 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/12/2020 4:56:17 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $54,693,000 +59.7% | Assets $45,392,000 | EPS -$1.23 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/12/2020 8:17:39 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $17,759,000 -34.3% | Assets $45,392,000 | EPS $0.02 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/7/2019 7:30:34 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $14,248,000 +2,049.0% | Assets $53,729,000 | EPS -$0.24 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/7/2019 6:58:09 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $14,248,000 +2,049.0% | Assets $53,729,000 | EPS -$0.24 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/15/2019 4:32:07 PM | View | Proxy | SEC | Y 2018 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/8/2019 4:21:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $12,247,000 +510.5% | Assets $55,242,000 | EPS -$0.52 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/8/2019 6:21:00 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $12,247,000 +510.5% | Assets $55,242,000 | EPS -$0.52 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/6/2019 4:20:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $10,439,000 +129.3% | Assets $61,044,000 | EPS -$0.50 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/6/2019 7:09:24 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $10,439,000 +129.3% | Assets $61,044,000 | EPS -$0.50 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 4/12/2019 5:02:21 PM | View | Proxy | SEC | Y 2018 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2019 9:17:28 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $34,240,000 +62.4% | Assets $61,131,000 | EPS -$1.80 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2019 7:37:10 AM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $663,000 -91.2% | Assets $65,747,000 | EPS -$0.40 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2019 7:27:09 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $2,006,000 -68.4% | Assets $51,721,000 | EPS -$0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2019 7:17:07 AM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $4,553,000 +57.6% | Assets $64,797,000 | EPS -$0.50 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/18/2019 7:00:21 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $27,018,000 +527.6% | Assets $61,131,000 | EPS -$0.40 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 1/4/2019 4:33:20 PM | View | Presentation | SEC | 1Q 2019 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 11/7/2018 4:48:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $663,000 -91.2% | Assets $65,747,000 | EPS -$0.40 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/7/2018 7:10:29 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $663,000 -91.2% | Assets $65,747,000 | EPS -$0.40 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/17/2018 4:32:25 PM | View | Proxy | SEC | Y 2017 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/9/2018 4:26:04 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $2,006,000 -68.4% | Assets $51,721,000 | EPS -$0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/9/2018 7:13:41 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $2,006,000 -68.4% | Assets $51,721,000 | EPS -$0.06 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2018 4:55:05 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $4,553,000 +57.6% | Assets $64,797,000 | EPS -$0.50 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2018 7:09:33 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $4,553,000 +57.6% | Assets $64,797,000 | EPS -$0.50 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/6/2018 4:25:19 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $21,078,000 +129.1% | Assets $72,214,000 | EPS -$6.37 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/6/2018 4:16:52 PM | View | Proxy | SEC | Y 2017 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/6/2018 7:48:19 AM | View | Financials | Earnings | SEC | Y 2017 | Rev $4,305,000 +106.9% | Assets $72,214,000 | EPS -$5.82 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 1/5/2018 4:07:49 PM | View | Presentation | SEC | 1Q 2018 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 11/8/2017 4:36:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $7,526,000 +61.2% | Assets $61,058,000 | EPS -$0.09 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/8/2017 7:07:46 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $7,526,000 +61.2% | Assets $61,058,000 | EPS -$0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 9/1/2017 4:04:24 PM | View | Proxy | SEC | Y 2016 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/25/2017 4:30:13 PM | View | Proxy | SEC | Y 2016 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/9/2017 4:23:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $6,358,000 +259.4% | Assets $59,000,000 | EPS -$0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/9/2017 7:06:55 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $6,358,000 +259.4% | Assets $59,000,000 | EPS -$0.06 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/10/2017 4:12:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $2,889,000 +325.5% | Assets $71,852,000 | EPS -$0.48 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/10/2017 7:44:20 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $2,889,000 +325.5% | Assets $71,852,000 | EPS -$0.48 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/16/2017 4:21:12 PM | View | Proxy | SEC | Y 2016 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 3/16/2017 4:08:15 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $9,199,000 +110.8% | Assets $82,247,000 | EPS -$0.29 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/16/2017 8:08:55 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $2,081,000 | Assets $82,247,000 | EPS -$0.02 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 1/9/2017 6:11:33 AM | View | Financials | Earnings (Prelim) | SEC | Y 2016 | Export Earnings Model | ||||
| Protalix BioTherapeutics, Inc. (PLX) | 11/9/2016 4:32:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $4,670,000 +249.6% | Assets $70,474,000 | EPS -$0.07 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/9/2016 8:09:48 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $4,670,000 +249.6% | Assets $70,474,000 | EPS -$0.07 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/8/2016 4:51:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $1,769,000 +32.4% | Assets $78,864,000 | EPS -$0.11 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/8/2016 4:40:12 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $1,769,000 +32.4% | Assets $78,864,000 | EPS -$0.11 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 7/1/2016 5:04:30 PM | View | Proxy | SEC | Y 2015 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2016 4:32:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $679,000 -59.9% | Assets $87,310,000 | EPS -$0.09 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2016 7:16:38 AM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $679,000 -59.9% | Assets $87,310,000 | EPS -$0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/8/2016 4:31:20 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $4,364,000 +23.9% | Assets $97,253,000 | EPS $0.61 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/8/2016 7:38:09 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $0 | Assets $97,253,000 | EPS $0.77 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/9/2015 4:42:15 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $1,336,000 -44.2% | Assets $59,492,000 | EPS -$0.04 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/9/2015 4:15:26 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,336,000 -44.2% | Assets $59,492,000 | EPS -$0.04 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/1/2015 4:30:50 PM | View | Proxy | SEC | Y 2014 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/10/2015 4:50:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $1,336,000 -44.9% | Assets $65,954,000 | EPS -$0.05 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/10/2015 4:37:42 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $1,336,000 -44.9% | Assets $65,954,000 | EPS -$0.05 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/7/2015 4:48:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $1,692,000 -74.7% | Assets $72,048,000 | EPS -$0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/7/2015 4:39:41 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $1,692,000 -74.7% | Assets $72,048,000 | EPS -$0.06 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/12/2015 4:45:59 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $3,523,000 | Assets $78,357,000 | EPS -$0.32 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/12/2015 4:30:17 PM | View | Financials | Earnings | SEC | Y 2014 | Rev ($7,994,000) | Assets $78,357,000 | EPS -$0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 1/5/2015 7:06:37 AM | View | Financials | Earnings | SEC | Y 2014 | Rev ($7,994,000) | Assets $78,357,000 | EPS -$0.09 | Export Earnings Model | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/10/2014 4:32:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $2,396,000 +4.9% | Assets $84,795,000 | EPS -$0.09 | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/9/2014 4:30:27 PM | View | Proxy | SEC | Y 2013 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/7/2014 4:30:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $2,425,000 +7.1% | Assets $96,651,000 | EPS -$0.07 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/8/2014 4:31:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $6,696,000 +87.7% | Assets $103,416,000 | EPS $0.08 | |
| Protalix BioTherapeutics, Inc. (PLX) | 3/13/2014 4:32:24 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $113,333,000 | EPS -$0.30 | ||
| Protalix BioTherapeutics, Inc. (PLX) | 11/7/2013 4:43:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $2,284,000 -38.7% | Assets $121,156,000 | EPS -$0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 9/19/2013 7:04:48 PM | View | Proxy | SEC | Y 2012 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 8/8/2013 4:31:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $2,264,000 -91.3% | Assets $62,306,000 | EPS -$0.07 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/9/2013 5:15:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $3,568,000 -7.6% | Assets $69,942,000 | EPS $0.05 | |
| Protalix BioTherapeutics, Inc. (PLX) | 2/28/2013 4:32:07 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $34,870,000 +315.8% | Assets $78,727,000 | EPS -$0.13 | |
| Protalix BioTherapeutics, Inc. (PLX) | 11/7/2012 4:06:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $3,724,000 +229.0% | Assets $77,378,000 | EPS $0.06 | |
| Protalix BioTherapeutics, Inc. (PLX) | 8/3/2012 5:23:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $26,113,000 +3,317.9% | Assets $84,304,000 | EPS $0.10 | |
| Protalix BioTherapeutics, Inc. (PLX) | 5/21/2012 8:12:03 AM | View | Proxy | SEC | Y 2011 | ||||||
| PROTALIX BIOTHERAPEUTICS, INC. (PLX) | 5/9/2012 4:33:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $3,861,000 -6.5% | Assets $68,464,000 | EPS $0.07 | |
| PROTALIX BIOTHERAPEUTICS, INC. (PLX) | 2/27/2012 4:13:18 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $8,386,000 +26.3% | Assets $51,805,000 | EPS -$0.43 | |
| Protalix BioTherapeutics, Inc. (PLX) | 2/15/2012 12:00:00 AM | View | Financials | Earnings | SEC | Y 2011 | Rev $2,362,000 +100.9% | Assets $51,805,000 | EPS -$0.40 | Export Earnings Model | |
| PROTALIX BIOTHERAPEUTICS, INC. (PLX) | 11/7/2011 4:09:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $1,132,000 -64.4% | Assets $60,829,000 | EPS -$0.10 | |
| Protalix BioTherapeutics, Inc. (PLX) | 9/19/2011 4:42:42 PM | View | Proxy | SEC | Y 2010 | ||||||
| PROTALIX BIOTHERAPEUTICS, INC. (PLX) | 8/8/2011 6:04:10 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $764,000 -33.0% | Assets $71,888,000 | EPS -$0.16 | |
| Protalix BioTherapeutics, Inc. (PLX) | 10/4/2010 4:46:35 PM | View | Proxy | SEC | Y 2009 | ||||||
| Protalix BioTherapeutics, Inc. (PLX) | 9/17/2009 7:47:03 PM | View | Proxy | SEC | Y 2008 |